CMT's CannaBiz Invest Asia Summit on 29-30 August, 2019 in Bangkok, zooms in on the legal and commercial aspects of medical and industrial cannabis market in Asia vis-à-vis government regulations, investments, cultivation and value added products.With more Asian countries starting to legalise medical and industrial cannabis use, major cannabis product manufacturers will convene in Bangkok for a timely summit to share insights on this new market.Aurora Cannabis shares insights on Global Cannabis Market Outlook & Investment Landscape. Day 1 also features sessions from cannabis producers – CannAcubed presenting a case study on 'China's Industrial Hemp Cultivation & Value Chain Investment' and ElixinolGlobal providing the 'Growth Outlook for Hemp Foods, Protein & the CBD Market in Japan & Globally'. Coffee break sponsor – Medipharm Labs will speak on Australia's Role in APAC Medical Cannabis Market.
Organised by Centre for Management Technology (CMT), the program also features sessionson: The Future of Sustainable Fashion & Hemp Fibres Industry - Kingdom Holdings "Green Green Profits" - The Cultivation of Outdoor Medical Cannabis as a Business Model for Asia - Jacana Holdings Commercialisation of Plant-Derived Cannabinoid Prescription Medicines to Meet Global Demand - MGC Pharmaceuticals Pharmaceutical Development in Man-Made Cannabinoids - Akseera Pharma
In addition, MYM Nutraceuticals, Helius Therapeutics and Cannex Capital join a panel discussion on 'Accessing Capital Markets for Cannabis Investments – Options & Challenges'.
Meet exhibitors Shenzhen Number Energy Saving Corporation and Blue Sky Biologicals among others at the event. For exhibition details, email [email protected]
Summit Day 1 29 Aug, 2019 - Thursday08:00Morning Registrations & Coffee09:00Chairman’s Welcome & Introduction09:10INTEGRATION OF MEDICAL CANNABIS IN THAI TRADITIONAL MEDICINE - A BALANCING GAMEResearch updates and plans moving forwardRaw materials sourcing & cultivation plansFuture patient access criteriaDr. Khwanchai Visithanon, DirectorDept of Thai Traditional and Alternative Medicine, Ministry of Health09:40UNDERSTANDING THE MEDICAL CANNABIS INVESTMENT LANDSCAPE & REGULATORY HURDLES IN THAILANDWho can invest and the value chain for participationWhat licenses and permits are required and which authorities to seek approval?Dissecting the regulations from imports of seeds/strains to cultivation, extraction & refining to distribution, orphan drugs & etcIntellectual Property consideration for cannabis investment in ThailandDr. Atthachai Homhuan, Manager, Regulatory AffairsTilleke & Gibbins International Ltd10:10CHINA – INDUSTRIAL HEMP CULTIVATION & VALUE CHAIN INVESTMENT CASE STUDYAccess to seeds varieties & cultivation investment challengesCBD Oil extraction and value additionTraceability and Compliance in the Cannabis Industry: Preparing for International Import and ExportGrowth potential in ChinaMr. Glenn Davies, Co-Founder & Group CEOCannAcubed Pte Ltd10:40Networking Refreshment11:10GLOBAL CANNABIS MARKET OUTLOOK & INVESTMENT LANDSCAPEUnlocking the cannabis market potential & challenges facing investors Cam Battley, Chief Corporate OfficerAurora Cannabis Inc.11:40FROM FARM TO PHARMACEUTICAL PRODUCTS – ISRAEL’S EXPERIENCEImportance of clinical trial for medical cannabisWill medical cannabis exports be a cash cow for Israel?How will it impact the global cannabis market?Dr. Tamir Gedo, CEOBOL Pharma Ltd12:10GROWTH OUTLOOK FOR HEMP FOODS, PROTEIN & THE CBD MARKET IN JAPAN & GLOBALLYMr. Paul Benhaim, CEOElixinol Global Ltd12:40Networking Lunch13:45Afternoon Chairman’s Introduction13:50ACCESSING CAPITAL MARKETS FOR CANNABIS INVESTMENTS – OPTIONS & CHALLENGESPanelists: Erick Factor, Executive Chairman & FounderMYM NutraceuticalsPaul Manning, Co founder and Excutive DirectorHelius TherapeuticsAnthony Dutton, CEOCannex Capital14:20CANNABIS LEGISLATION IN NEW ZEALAND: REFLECTIONS ON GOVERNMENT EFFORTS TO DESIGN WORLD-LEADING MEDICINAL CANNABIS & FULL LEGALISATIONRecent developments in New Zealand include the passing of Medicinal Cannabis legislation in 2018 and the current drafting of legislation for full legalisation that will be the subject of a national referendum in 2020. New Zealand is an advanced economy with a small population and strong democracy. Starting after other jurisdictions, the country has been able to take the best of existing examples around the globe to design world-leading legislation and regulations for the legal production and use of cannabis.Mr. Manu Caddie, CEOHikurangi Cannabis Company14:50OUTLOOK OF THE MEDICAL CANNABIS INDUSTRY IN AUSTRALIAAustralian Cannabis Laws at a GlanceMedical cannabis research, production & clinical trials updateEconomics of production for local and export marketsMedical professional’s attitude towards medical cannabis, prescription and patient access challenges15:20Networking Refreshment15:50HEMP: BEYOND CBD & THC, A WHOLE PLANT MODELA plant that we have had a 5000+ year history with it gaining worldwide acceptance once again and the entire benefits of this plant are still mostly unknown. The hemp plant delivers tremendous benefits in the areas of Food, Fibre and Medicine and we will explore all of these areas with a focus on the medicine, which we have only begun to truly understand.Preet Marwaha, CEOBlue Sky Biologicals16:20THE FUTURE OF SUSTAINABLE FASHION & HEMP FIBRES INDUSTRYMr. Andy Chan, CFOKingdom Holdings Limited16:50CBD – THE NEXT BIG THING IN BEAUTY?Emerging trends & market size for CBD infused beauty & wellness productsHow regulation will affect the CBD beauty industry & supply chain?Formulation & standardsMarketing & distribution channels17:20End of Day One
Summit Day 230 Aug, 2019 - Friday09:00Chairman’s Introduction09:10INDUSTRIAL AND MEDICAL CANNABIS INVESTMENT IN INDIA – SCIENTIFIC AND LEGAL PERSPECTIVECannabis – India’s next Green revolution & what the future holds?BOHECO’s scientific, policy & commercial endeavours to bring Hemp into the mainstream in IndiaInnovations with Industrial Hemp & Medicinal Cannabis – What’s in store from an India & Asia horizonNavigating legal landscape moving forwardMr. Jahan Peston Jamas, Co-founder & & Director, Strategic Development and CollaborationsBombay Hemp Company Private Limited (BOHECO)09:40“GREEN GREEN PROFITS” - THE CULTIVATION OF OUTDOOR MEDICAL CANNABIS AS A BUSINESS MODEL FOR ASIACultivation Methods and Facility Design - Outdoor vs. Indoor, Advantages and DisadvantagesSustainability - Why it should be an integral part of your business modelQuality Assurance - How outdoor grown medical cannabis can meet and exceed international quality standardsMr. Markus Hoffmann, VP of Business DevelopmentJacana Holdings Inc.10:10LATEST EXTRACTION & REFINING TECHNOLOGIES - PERSPECTIVE FROM BIOTECH COMPANIES10:40Networking Refreshment11:10CANNABIS SEEDS & STRAINS SELECTIONEffect of Variety on Crop Yield and Cannabinoid ContentPlant variety protection11:40COMMERCIALIZATION OF PLANT-DERIVED CANNABINOID PRESCRIPTION MEDICINES TO MEET GLOBAL DEMANDPlans beyond CannEpilEnsuring supply & ensuring consistency in plant-based raw materials for commercial productionClearing regulatory approvals for global distributionMr. Blaise Bratter, Australia Operations ManagerMGC Pharmaceuticals Ltd12:10PHARMACEUTICAL DEVELOPMENT IN MAN-MADE CANNABINOIDSGenetic engineering and the prospect of man-made cannabinoidsIs it a more economical & regulatory-friendly alternative to natural CBD?Mr. Manit Patel, Chief Executive OfficerAkseera Pharma Corp12:40Final Discussion followed by Closing Lunch
Aug 29-30 2019
CannaBiz Invest Asia
Aug 29 2019
Entering Cannabis: Startup Stories
Los Angeles, United States